DEXCOM INC — Director's Dealing 2020

Sep 12, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2020-09-09

Reporting Person: MOY JEFFREY (EVP Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-09-09	Common Stock	J	6967	$0.0	Disposed	19684	Direct
2020-09-09	Common Stock	J	6967	$0.0	Acquired	38364	Indirect
2020-09-09	Common Stock	D	1003	$398.302	Disposed	37361	Indirect
2020-09-09	Common Stock	D	2577	$398.302	Disposed	34784	Indirect

Footnotes

F1: Shares were transferred from direct ownership to ownership under the Moy Family Trust upon vesting of previously awarded restricted stock units.

F2: Included in this number are 19,684 unvested restricted stock units, 8,811 of which were granted on March 8, 2020 and shall vest through March 8, 2023, 5,857 of which were granted on March 8, 2019 and shall vest through March 8, 2022, and 5,016 of which were granted on March 8, 2018 and shall vest through March 8, 2021.

F3: Shares are held by the Moy Family Trust U/A/D 12/09/2013, with respect to which the reporting person is a trustee.

F4: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.